English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu“Justice supports triage priority for those with better initial survival prognosis, but opposes considering subsequent life-years saved,” according to a special editorial by John R. Stone, MD, PhD, Professor of Bioethics and Co-Founder and Co-Executive Director of the Center for Promoting Health and Health Equity at Creighton University, Omaha. He adds: “Groups experiencing historical and current inequities must have significant voices in determining triage policy.”
‘Justice-Respect-Worth’ Framework Calls for Rethinking COVID-19 Triage
Recent articles have proposed frameworks for making the “terrible choices” posed by COVID-19 – focused on maximizing the benefits of treatment based on life-years saved. In one approach, patients with lower “prognosis scores” get lower priority for critical care.
But the focus on counting life-years violates “the foundational moral framework of social justice, respect for persons, and people’s equal and substantial moral worth,” Dr. Stone writes. In particular, prioritizing treatment for patients with a better prognosis will give lower priority, on average, “to individuals for whom social/structural inequities are significant causes of worse health” – with racial/ethnic minorities being a key example.
“Historical and present inequities have reduced expected life-years in populations experiencing chronic disadvantage,” according to the author. “Justice requires avoiding policies that further increase inequities…greater priority for more predicted life-years saved will exacerbate those inequities.”
A more just approach would be to consider the individual’s likelihood of initial survival, while ignoring subsequent life-years saved. “Triage policies can reasonably give priority to people more likely to survive hospitalization and a brief time after,” Dr. Stone writes.
By this approach, a younger and older patient would have similar priority for lifesaving care– as long as they had a similar chance of surviving for more than a few months after leaving the hospital. (Dr. Stone adds that bias against the elderly is another reason not to prioritize life-years gained.)
While guidance for triage decisions tries to ensure objectivity, assessments may still be affected by implicit and unconscious negative bias. For that reason, specific diversity on triage teams is essential. Policy decision-makers must include representatives of “populations historically oppressed and disadvantaged,” according to the author.
Dr. Stone highlights the importance of the “justice-worth-respect” framework in making difficult decisions about which patients should be prioritized for scare healthcare resources. He concludes: “Triage policies focused on life-years saved will perpetuate social injustice and generally should be rejected.”
Click here to read “Social Justice, Triage, and COVID-19: Ignore Life-years Saved.”
DOI: 10.1097/MLR.0000000000001355
###
About Medical Care
Rated as one of the top ten journals in health care administration, Medical Care is devoted to all aspects of the administration and delivery of health care. This scholarly journal publishes original, peer-reviewed papers documenting the most current developments in the rapidly changing field of health care. Medical Care provides timely reports on the findings of original investigations into issues related to the research, planning, organization, financing, provision, and evaluation of health services. In addition, numerous special supplementary issues that focus on specialized topics are produced with each volume. Medical Care is the official journal of the Medical Care Section of the American Public Health Association.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
Original post https://alertarticles.info
